Reply to 'Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes' by Yoshimoto et al

J Investig Med. 2018 Feb;66(2):e4. doi: 10.1136/jim-2017-000569. Epub 2017 Oct 13.

Authors

David León Jiménez¹, Ramón Pérez Temprano², Rocío Ruiz Hueso¹, José Manuel Lopéz Chozas³, José Pablo Miramontes González⁴

Affiliations

¹ Department of Internal Medicine, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
² Department of Internal Medicine, Vascular Unit, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
³ Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Sevilla, Andalucía, Spain.
⁴ Department of Internal Medicine, Hospital Universitario de Salamanca, IBIS, Salamanca, Castilla y León, Spain.

PMID: 29030417
DOI: 10.1136/jim-2017-000569

No abstract available

Keywords: diabetes mellitus; renin.

Publication types

Letter
Comment

MeSH terms

Albuminuria
Angiotensinogen*
Diabetes Mellitus, Type 2*
Glucose
Humans
Hypoglycemic Agents
Sodium

Substances

Hypoglycemic Agents
Angiotensinogen
Sodium
Glucose